Changes in calcanean bone mineral occurring spontaneously and during hormone replacement therapy in early post-menopausal women
- PMID: 1336890
- DOI: 10.3109/00365519209088388
Changes in calcanean bone mineral occurring spontaneously and during hormone replacement therapy in early post-menopausal women
Abstract
The spontaneous calcanean bone loss occurring in healthy early post-menopausal women and the effect of two hormone replacement therapies (HRT's) were investigated in a longitudinal study. There was no difference between the right and left calcanean BMC or BMD (p > 0.15). The spontaneous bone loss was similar at all the skeletal sites measured, with a mean spontaneous loss in calcanean BMD of 1.6% over one year. Both HRT's significantly (p < 0.01) prevented the bone loss from all skeletal sites irrespective of the weight-bearing or content of trabecular bone, and (for the weight-bearing bones) there was even a gain in calcanean BMC and BMD and spinal BMD (p < 0.01). Bone mineral of the calcaneus and the spine correlated equally to body weight (r approximately 0.4, p < 0.001), whereas bone mineral in the forearm was not correlated to body weight. The correlations between the changes in bone mineral at the sites measured were all significant (r approximately 0.2-0.4).
Similar articles
-
Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.Osteoporos Int. 2005 Apr;16(4):372-9. doi: 10.1007/s00198-004-1773-4. Epub 2005 Jan 15. Osteoporos Int. 2005. PMID: 15654581 Clinical Trial.
-
Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages.Clin Endocrinol (Oxf). 1996 Jan;44(1):79-84. doi: 10.1046/j.1365-2265.1996.637459.x. Clin Endocrinol (Oxf). 1996. PMID: 8706298 Clinical Trial.
-
[Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].Ginecol Obstet Mex. 2004 Jul;72:349-55. Ginecol Obstet Mex. 2004. PMID: 15469174 Spanish.
-
Effects of specific post-menopausal hormone therapies on bone mineral density in post-menopausal women: a meta-analysis.Hum Reprod. 2003 Aug;18(8):1737-46. doi: 10.1093/humrep/deg315. Hum Reprod. 2003. PMID: 12871893
-
Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.Expert Rev Clin Pharmacol. 2014 May;7(3):281-91. doi: 10.1586/17512433.2014.893819. Epub 2014 Mar 3. Expert Rev Clin Pharmacol. 2014. PMID: 24580081 Review.
Cited by
-
Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women.Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002229. doi: 10.1002/14651858.CD002229.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2013 Apr 30;(4):CD002229. doi: 10.1002/14651858.CD002229.pub3. PMID: 15846631 Free PMC article. Updated.
-
Hormone therapy for preventing cardiovascular disease in post-menopausal women.Cochrane Database Syst Rev. 2015 Mar 10;2015(3):CD002229. doi: 10.1002/14651858.CD002229.pub4. Cochrane Database Syst Rev. 2015. PMID: 25754617 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical